FDA Inspection 1271003 — Department of Defense - Army (Armed Services Blood Program)

Department of Defense - Army (Armed Services Blood Program) — FEI 3002964709

The FDA completed an inspection of Department of Defense - Army (Armed Services Blood Program) on April 10, 2025 in Landstuhl. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 10, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Landstuhl (Germany)